Have a feature idea you'd love to see implemented? Let us know!

CLB Core Laboratories N V

Price (delayed)

$19.38

Market cap

$909.89M

P/E Ratio

33.41

Dividend/share

$0.04

EPS

$0.58

Enterprise value

$1.08B

Core Laboratories N.V. is a leading provider of proprietary and patented reservoir description and production enhancement services and products used to optimize petroleum reservoir performance. The Company has over 70 ...

Highlights
CLB's debt is down by 15% YoY and by 3.1% from the previous quarter
CLB's equity is up by 12% YoY and by 4.4% from the previous quarter
CLB's net income is down by 36% year-on-year but it is up by 10% since the previous quarter
Core Laboratories N V's EPS has decreased by 34% YoY but it has increased by 12% from the previous quarter
The gross margin has decreased by 6% YoY and by 2.4% QoQ
CLB's gross profit is down by 3.5% year-on-year

Key stats

What are the main financial stats of CLB
Market
Shares outstanding
46.95M
Market cap
$909.89M
Enterprise value
$1.08B
Valuations
Price to book (P/B)
3.63
Price to sales (P/S)
1.74
EV/EBIT
18.67
EV/EBITDA
14.8
EV/Sales
2.07
Earnings
Revenue
$522.82M
EBIT
$58.04M
EBITDA
$73.2M
Free cash flow
$45.04M
Per share
EPS
$0.58
Free cash flow per share
$0.96
Book value per share
$5.34
Revenue per share
$11.14
TBVPS
$10.54
Balance sheet
Total assets
$600.47M
Total liabilities
$344.05M
Debt
$195.03M
Equity
$250.74M
Working capital
$140.29M
Liquidity
Debt to equity
0.78
Current ratio
2.48
Quick ratio
1.46
Net debt/EBITDA
2.37
Margins
EBITDA margin
14%
Gross margin
20.5%
Net margin
5%
Operating margin
11.3%
Efficiency
Return on assets
4.4%
Return on equity
11.1%
Return on invested capital
9.9%
Return on capital employed
11.5%
Return on sales
11.1%
Dividend
Dividend yield
0.21%
DPS
$0.04
Payout ratio
6.9%

CLB stock price

How has the Core Laboratories N V stock price performed over time
Intraday
-2.42%
1 week
-4.77%
1 month
-10.32%
1 year
11.12%
YTD
9.74%
QTD
4.59%

Financial performance

How have Core Laboratories N V's revenue and profit performed over time
Revenue
$522.82M
Gross profit
$106.98M
Operating income
$58.96M
Net income
$26.2M
Gross margin
20.5%
Net margin
5%
CLB's net margin is down by 38% YoY but it is up by 9% from the previous quarter
CLB's net income is down by 36% year-on-year but it is up by 10% since the previous quarter
Core Laboratories N V's operating income has increased by 10% QoQ and by 6% YoY
The operating margin has increased by 8% from the previous quarter and by 3.7% YoY

Growth

What is Core Laboratories N V's growth rate over time

Valuation

What is Core Laboratories N V stock price valuation
P/E
33.41
P/B
3.63
P/S
1.74
EV/EBIT
18.67
EV/EBITDA
14.8
EV/Sales
2.07
Core Laboratories N V's EPS has decreased by 34% YoY but it has increased by 12% from the previous quarter
The stock's price to earnings (P/E) is 31% less than its 5-year quarterly average of 48.3 but 17% more than its last 4 quarters average of 28.6
The P/B is 50% below the 5-year quarterly average of 7.3
CLB's equity is up by 12% YoY and by 4.4% from the previous quarter
CLB's price to sales (P/S) is 17% lower than its 5-year quarterly average of 2.1 but 2.4% higher than its last 4 quarters average of 1.7
The company's revenue rose by 2.7% YoY

Efficiency

How efficient is Core Laboratories N V business performance
The return on equity has declined by 45% year-on-year but it rose by 8% since the previous quarter
The ROA has contracted by 37% YoY but it has grown by 10% from the previous quarter
The return on invested capital is up by 10% since the previous quarter and by 8% year-on-year
Core Laboratories N V's ROS has increased by 7% from the previous quarter

Dividends

What is CLB's dividend history
DPS
$0.04
Dividend yield
0.21%
Payout ratio
6.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Core Laboratories N V financials performed over time
The total assets is 75% greater than the total liabilities
CLB's current ratio is down by 8% year-on-year but it is up by 3.8% since the previous quarter
The quick ratio has increased by 7% QoQ and by 2.1% YoY
CLB's debt is 22% less than its equity
The debt to equity has decreased by 24% YoY and by 7% QoQ
CLB's debt is down by 15% YoY and by 3.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.